Practice Management Agreements for Rheumatology Clinics: PMA Structures and Financial Planning 2026

What is a Practice Management Agreement?

A practice management agreement is a contract between a physician-owned or physician-led healthcare practice and a third-party management company that oversees business operations, billing, scheduling, compliance, and staffing on behalf of the clinical team. The PMA defines revenue sharing, governance rights, term length, performance obligations, and exit conditions.

For rheumatology practices, a PMA structures the relationship between clinical providers—rheumatologists, advanced practice providers, nurses, and medical support staff—and the business entity that runs the practice. The physician retains clinical autonomy and patient relationships; the management company handles administration, allowing the practice to scale without duplicating overhead.

Why Rheumatology Practices Use PMAs

Rheumatology is capital-intensive. Running a modern clinic requires diagnostic imaging equipment, laboratory capacity, infusion suites, electronic health records (EHR) systems, and compliance infrastructure for handling biologics and controlled substances. These costs create barriers to practice ownership and expansion.

Practice management agreements remove some of these barriers by:

• Spreading infrastructure costs across multiple clinics in the network, reducing per-site capital requirements for medical equipment financing 2026.
• Centralizing administrative burden, freeing rheumatologists to see more patients and focus on clinical outcomes.
• Providing working capital that the management company may advance to support seasonal cash flow dips or growth investments in rheumatology practice business loans.
• Enabling rapid scaling, allowing a single physician or small group to grow from one clinic to multiple locations without building an independent business infrastructure.

In return, the management company takes a percentage of revenue or a fixed monthly fee, depending on the agreement structure.

PMA Structures: The Main Variants

Revenue-Share Model

The management company receives a percentage of gross collections—typically 6–12%, though rates vary by specialty and geography. The physician or practice receives the remainder. Revenue-share PMAs work best for established practices with predictable, high-volume cash flow because the management company's incentive aligns directly with clinical productivity.

Pros: Transparent cost structure tied to actual revenue; lower fixed costs in lean months.

Cons: As revenue scales, the percentage paid to management can feel expensive; if revenue drops, the clinic absorbs all the loss while still paying the percentage.

Fixed-Fee Model

The management company charges a flat monthly or annual fee—often $15,000–$50,000 per month, depending on clinic size and service scope. The practice keeps all revenue above that fee.

Pros: Predictable costs; strong incentive for the practice to maximize revenue since most income above the fee stays in-house.

Cons: High fixed costs burden small or new clinics; if patient volume drops, the fee doesn't adjust, squeezing margins. Many fixed-fee PMAs include volume adjustments or require minimum revenue guarantees that protect the management company.

Hybrid Model

A base monthly fee (often $8,000–$20,000) plus a smaller percentage of revenue above a threshold (e.g., 3–5% of collections over $200,000 per month). This balances predictability with alignment.

Pros: Blends cost predictability with upside sharing; common in mid-size rheumatology networks.

Cons: More complex to audit; disputes can arise over what counts toward revenue thresholds and fee adjustments.

Equity-Based Model

Rarer but growing: the management company takes an ownership stake (10–49%) in the practice and operates more like a partner. Revenues are split based on ownership percentage after operating costs. This model is typical in larger platform acquisitions where the management company wants long-term alignment.

Pros: Strongest alignment between management company and physician success; clearer governance and exit paths.

Cons: Physician surrenders some control; exit is more complicated because the management company is a co-owner. Often requires formal buy-sell agreements and valuations.

Key Negotiation Points for Rheumatology Practice Owners

1. Revenue Definition and Calculation

What counts as "revenue" in a percentage-based PMA? Definitions matter enormously:

• Gross collections: All patient and insurance payments received. Most management companies use this.
• Net collections: Gross collections minus contractual adjustments (insurer write-downs). Physicians prefer this, as it removes bad-debt risk from the calculation.
• Patient care revenue only: Excludes ancillary income (lab work, imaging, retail products). Critical if your practice generates significant non-core revenue.

Negotiate a clear definition. For low interest practice expansion loans tied to revenue covenants, the lender will need to verify this definition matches the loan agreement.

2. Term Length and Renewal

PMA terms typically run 3–5 years with automatic renewal unless either party provides notice. Consider:

• Initial term: Longer initial terms (5+ years) give the management company confidence to invest in systems; shorter terms (2–3 years) give you flexibility if the partnership isn't working.
• Performance triggers: Tie renewal to specific metrics—patient volume growth, patient satisfaction scores, revenue retention. If the management company underperforms, you should have grounds to renegotiate or exit.
• Renewal pricing: Does the fee percentage or fixed fee adjust at renewal? Specify caps (e.g., fees cannot increase >10% per renewal period) to prevent surprise cost spikes.

3. Control and Governance

Which decisions require your approval?

• Hiring and firing clinical and administrative staff
• Capital expenditures above a threshold (typically $25,000–$50,000)
• Major service line changes (e.g., adding or removing infusion services)
• Contract negotiations with payers and suppliers
• Selling or relocating the practice

Insist on clinical governance: the management company should not hire, fire, or direct clinical staff without your sign-off. Operational decisions (hiring a billing manager, switching EHR vendors, negotiating vendor contracts) are fair game for management.

4. Exit and Termination

A well-drafted termination clause protects both parties:

For-cause termination: Either party can terminate immediately if the other materially breaches and fails to cure within 30–60 days. Examples: the physician fails to maintain licensure; the management company fails to process claims within agreed timelines; either party commits fraud.

Without-cause termination: Either party can terminate without cause with 90–180 days notice. Often includes a penalty—the management company may retain a portion of that month's fee or the physician pays a small exit fee (e.g., 1–2 months of fees).

Non-compete: Most PMAs include a 1–3 year non-compete barring the physician from opening a competing practice within a certain radius. This is standard but negotiable; try to narrow the geographic scope or duration if you anticipate independent practice later.

Tail Services: If you terminate, the management company may charge a "tail" fee (typically 1–3 months of management fees) to wind down operations, collect final receivables, and hand off records. Budget for this in your exit planning.

5. Financing and Capital Responsibility

Clarify who pays for what:

• Equipment: Does the management company fund medical equipment financing 2026, or do you? If they fund, do you own it outright or do they retain title? (Title retention weakens your balance sheet for personal financing.)
• Facility: Does the management company lease the space and sub-lease to you, or do you lease directly? Sub-leasing through management creates an extra layer of cost and complicates exit.
• Working Capital: Who fronts cash if patient billing lags? Many PMAs include provisions allowing the management company to advance working capital for rheumatology clinics during startup or growth phases, with repayment from future revenue. Ensure terms are clear—is it an interest-free loan, does it accrue interest, and how is repayment prioritized?
• Debt Responsibility: If you borrow to fund equipment or working capital, are you personally guaranteed, or does the practice entity borrow? Negotiate to limit personal guarantees if possible.

PMA Financing Implications: Working Capital and Debt Capacity

A PMA affects your borrowing capacity and financial structure. Lenders evaluating rheumatology practice business loans care about:

Revenue Stability: A PMA should provide forecast-ability. Lenders want to see contracts guaranteeing minimum revenue or a stable patient panel. If the PMA allows the management company to terminate without cause, your revenue is less certain, and lenders may charge higher rates or require larger down payments.

Cash Flow After Fees: Your actual cash flow to service debt is revenue minus management fees. A 10% management fee on $800,000 annual revenue is $80,000; a lender will calculate your debt-service capacity on $720,000, not $800,000. Make sure your practice's post-fee cash flow supports your loan terms.

Leverage and Covenants: Healthcare bridge loans for physicians and equipment financing often include debt covenants—minimum revenue levels, maximum leverage ratios, or requirements to maintain certain working capital reserves. A PMA that ties your revenue to management performance can make these covenants harder to maintain if performance dips. Negotiate covenants that account for ordinary seasonal fluctuations in rheumatology patient volume.

Collateral and Liens: If you pledge practice receivables as collateral for a loan, ensure the PMA doesn't give the management company a lien on those receivables. Similarly, if the practice owns equipment, confirm that liens from equipment financing don't interfere with the management company's operational control.

How to Structure a PMA for Tax Efficiency

Tax deductions for medical expenses 2026 differ based on PMA design:

If You Own the Practice Entity: You deduct management fees as business expenses. If the practice is an S-Corp or LLC taxed as a partnership, these deductions flow to your personal return. Equipment purchased by the practice is capitalized and depreciated (typically over 5–7 years for medical equipment), or you may claim Section 179 expensing to deduct up to $1,160,000 in equipment purchases in the year acquired (2026 limit; adjusts annually for inflation).

If the PMA Owns Equipment: You typically deduct lease or rental payments on equipment. This is often less tax-efficient than owning and depreciating (especially with Section 179), but it reduces upfront capital and improves cash flow. Consult a healthcare tax advisor on whether the leased equipment qualifies for operating lease accounting or capital lease accounting under your practice structure.

If the Management Company Funds a Loan: The loan balance may not reduce your personal debt capacity if it's structured as a practice obligation with no personal guarantee. This is favorable for your personal credit profile but may increase the practice's debt burden, affecting reinvestment and distributions to you.

Negotiating PMA Terms: A Practical Checklist

1. Define Revenue and Fee Structure

• Confirm gross vs. net collections definition.
• Specify what revenue is excluded (e.g., ancillary revenue, grants, research income).
• Lock in fee percentage or fixed amount; clarify renewal pricing caps.
• Request a detailed 12-month cost breakdown so you understand all-in fees.

2. Outline Governance and Control

• Secure clinical autonomy: clinical hiring, credentialing, and peer review decisions remain yours.
• Define capital expenditure approval thresholds and authority.
• Specify decision-making for major service changes.

3. Clarify Financing and Capital

• Document who owns equipment and who pays for replacements.
• Define working capital advance terms (principal, interest, repayment timeline).
• Confirm whether you're personally liable for practice debt or only the practice entity is liable.

4. Establish Clear Exit Terms

• Negotiate notice period (90–180 days) and termination penalties.
• Limit non-compete scope and duration (aim for 1–2 years within 5 miles).
• Clarify tail wind-down costs and receivables collection process.
• Request a buy-sell or practice valuation formula so you know your exit value upfront.

5. Secure Compliance and Audit Rights

• Reserve the right to audit management company records quarterly.
• Require monthly financial reporting with revenue, expenses, and net income.
• Specify key performance indicators (KPIs) like claim denial rates, average days to payment, and patient satisfaction.

Working Capital for Rheumatology Clinics Under a PMA

Rheumatology practices have unique working capital needs:

Patient Mix: Rheumatology patients are often Medicare or commercial insured with deductibles and co-insurance. Biologic therapy cost assistance programs can ease patient out-of-pocket burden, but they add administrative complexity and may delay payment. Practices typically wait 30–60 days for full reimbursement, requiring a cash cushion to cover payroll, rent, and supplies.

Inventory: Biologics and specialty drugs must be in stock. Large-volume infusion clinics may carry $50,000–$200,000 in drug inventory at any time. Finance this through practice cash flow or PMA working capital advances. Some PMAs include drug purchasing arrangements with preferred suppliers, reducing your upfront cash tied up in inventory.

Seasonal Variation: Some practices see volume peaks in winter (more acute flares) and troughs in summer. Budget working capital to cover low-revenue months without cutting payroll or delaying payments to suppliers.

A typical rheumatology practice should maintain 3–6 months of operating expenses (payroll, rent, utilities, supplies) as working capital. Under a PMA, ask whether the management company will advance shortfalls during low-revenue periods or whether you must pre-fund reserves yourself.

Comparing PMA vs. Independent Practice Ownership

PMA Advantages:

• Lower upfront capital; management company often funds infrastructure.
• Shared operational overhead; lower per-site cost for billing, HR, compliance.
• Access to scale and network effects; faster growth potential.
• Risk mitigation; management company absorbs some operational risk.
• Easier exit; transition to another PMA or independent practice more straightforward.

PMA Disadvantages:

• Loss of revenue to management fees; fees typically 6–12% of gross collections.
• Reduced control over business decisions; you share governance with management company.
• Inflexibility in practice culture and operations; forced to adopt management company's systems.
• Limited upside if practice grows significantly; you give up a percentage of that growth.
• Longer-term tie-in; exiting early is costly (non-compete, tail fees, penalties).

Independent Practice Advantages:

• Full revenue retention; 100% of collections stay in the practice (minus your own operating expenses).
• Complete control; you set strategy, culture, staffing, systems.
• Unlimited upside; practice growth flows entirely to owner benefit.
• Freedom to pivot or exit; no long-term contractual obligations.

Independent Practice Disadvantages:

• High upfront capital required; you fund all equipment, facilities, and systems.
• Full operational burden; you manage billing, compliance, HR, credentialing directly.
• Higher overhead per-site; fixed costs (rent, admin staff) harder to scale.
• Slower growth; capital constraints limit expansion.
• Higher personal stress and time commitment; business runs on your effort.
• Requires strong business acumen; many physicians lack finance and operations expertise.

The right choice depends on your priorities: do you want maximum control and upside, or do you prioritize simplicity, lower capital needs, and risk-sharing?

Regulatory and Compliance Considerations

PMAs must comply with several regulatory frameworks:

Stark Law (Physician Self-Referral Law): Federal law prohibits physician referrals to entities with which they (or family members) have a financial relationship, except for narrow exceptions. A PMA is generally compliant if it involves fair-market-value compensation, written agreement, and legitimate business purpose. Work with a healthcare attorney to ensure your PMA structure passes Stark scrutiny.

Anti-Kickback Statute (AKS): Federal law prohibits payments designed to induce referrals. PMAs can run afoul of AKS if the management company's fees are structured as inducements to refer patients or order services. Keep compensation arm's-length and tied to legitimate business functions, not referral volume.

Corporate Practice of Medicine: Some states (including California, Texas, and Florida) prohibit lay persons or corporations from owning or operating medical practices. If you're in a corporate practice of medicine state, a PMA must preserve physician ownership and control; the management company can't own the practice entity. Structure PMAs carefully in these states, often using a management services agreement (MSA) rather than a full PMA.

State Licensing and Credentialing: Confirm that the PMA doesn't interfere with your medical license or hospital credentialing. You retain full clinical and legal responsibility for patient care, regardless of PMA administrative outsourcing.

Financial Planning: When to Consider a PMA vs. When to Build Independent

Consider a PMA if:

• You're starting a practice and lack $150,000–$300,000 in capital.
• You want to open multiple locations quickly without managing separate administrative teams.
• You prioritize clinical work over business operations.
• You want shared risk; you're risk-averse.
• You value access to a network and vendor relationships.

Build independently if:

• You have sufficient capital ($200,000+) or access to healthcare bridge loans for physicians at acceptable rates.
• You want maximum profit retention and full control.
• You have business experience or a strong CFO partner.
• You plan to sell the practice in 5–10 years; independent ownership commands higher valuations.
• You anticipate rapid growth and want unlimited upside.

Bottom Line

Practice management agreements offer a legitimate pathway to practice ownership for rheumatologists who lack upfront capital or want to minimize operational burden. However, PMAs cost money—typically 6–12% of revenue—and require you to share control and some upside. Before signing, negotiate term length, revenue definitions, governance rights, exit clauses, and financing provisions carefully. Work with a healthcare attorney and accountant to ensure the PMA aligns with your financial goals and doesn't create unintended tax or liability issues. Your choice between a PMA and independent ownership should reflect your priorities: capital constraints and operational preferences on one hand, long-term profit and control on the other.

If you're exploring financing options for a rheumatology practice, whether as an independent clinic or under a PMA, contact a healthcare lender to learn about current rates and programs tailored to physician-led practices.

Disclosures

This content is for educational purposes only and is not financial advice. rheumaevidence1.com may receive compensation from partner lenders, which may influence which products are featured. Rates, terms, and availability vary by lender and applicant qualifications.